in respect of their influence on insulin pharmacokinetics , moderate concentrations of insulin antibodies may be of positive advantage to all diabetics without endogenous insulin secretion and are not responsible for the insulin resistance of type 1 diabetes .
C0021641
insulin
C0011854
type 1